| k.thaele@thaelecom.de | | Thaele Consulting | | Tremsbüttel | | Germany | | www.thaele-consulting.de | | Company profile
Services for small and start up pharmaceutical companies:
Preparation of regulatory dossiers,
* Investigational Medicinal Product Dossiers (IMPD),
* Preparation of quality documentation and expert reports (modul 2.3 and modul 3),
Solutions for preparation and release of clinical supplies,
Qualified person (drug law),
Interimsmanagement (research and development, quality management)
Project management, R&D projects | | Main activity/research area
Medicine, Human Health, Pharmaceutical Products / Drugs, | | Process analysis, quality management, auditing (DIN EN ISO 9001) | | Main cooperation areas
Services for small and start up pharmaceutical companies
|
|
| nutzhorn@cytocentrics.com | | Cytocentrics AG | | Rostock | | Germany | | www.cytocentrics.com | | Company profile
Cytocentrics uses its patch clamp expertise to create leading edge tools for ion channel research. Cytocentrics’ headquarters are located in Rostock, Germany and maintain direct sales, service and application support and state-of-the-art laboratories.
Market Cytocentrics is currently addressing one major market: patch clamp in safety pharmacology and early profiling. Strategy With its patch clamp knowledge, Cytocentrics has positioned itself to streamline day-to-day work in patch clamp laboratories. Key Highlights:
· Tools company for patch clamp applications
· Founded in 2001 as a spin-off from the Natural and Medical Sciences Institute at the University of Tuebingen (NMI), Germany.
· Broad patent estate in planar patch clamp technology and cell biology · Product offering addresses entire area of patch clamp and has been validated by mid-size pharma to reduce costs, generate high quality data and increase efficiencies.
· Experienced management team with scientific and commercial experience Products
· CytoPAQ Instant Cells system, a ready-to-use kit including hERG-HEK293 Instant Cells and Cell Reservoir (PAQ = validated in Performance, Accuracy, Quality).
· Cell Line Adaptation to the CytoPAQ Instant Cells system. · Ion Channel Screening Services with an emphasis on cardiac safety (hERG Pharmacology) and assay development.
· CytoPatchTM instrument for automated patch clamp will be launched in the latter part of 2008 . | | Main activity/research area
Laboratory Equipment, Biology / Biotechnology , Micro- and Nanotechnology related to Biological sciences | | Safety Pharmacology | | Main cooperation areas
CytoPAQ Instant Cells system, a ready-to-use kit including hERG-HEK293 Instant Cells and Cell Reservoir (PAQ = validated in Performance, Accuracy, Quality). · Cell Line Adaptation to the CytoPAQ Instant Cells system. · Ion Channel Screening Services with an emphasis on cardiac safety (hERG Pharmacology) and assay development.
|
|
| krupp@amp-tec.com | | AmpTec GmbH | | Hamburg | | Germany | | www.amp-tec.com | | Company profile
AmpTec GmbH was founded in June 2005. The ExpressArttechnology was developed since 1998 at artus GmbH. After acquisition oft he PCR branch by Qiagen AG, the ExpressArt branch with all its personnel and know-how was transferred to AmpTec GmbH. Company Goals: Further development and extended applications of ExpressArt®, a unique linear mRNA amplification technology for analysing difficult samples (picograms of RNA, degraded RNA, FFPE RNA, bacterial mRNA) by genome-wide gene expression microarrays and by qPCR. | | Main activity/research area
Medicine, Human Health, Diagnostics, Diagnosis, Medical Research, Biology / Biotechnology , Micro- and Nanotechnology related to Biological sciences | | | | Main cooperation areas
Gene expression studies with main applications in characterization of tumours, stem cells, pathological tissues (laser microdissection) including treatment monitoring, embryonic and developmental stages, etc.; microscopic bacterial samples for drug development, profiling of environmental samples, etc.
|
|
| valdur.mikita@asperbio.com | | Asper Biotech Ltd | | Tartu | | Estonia | | www.asperbio.com | | Company profile
Asper Biotech, founded in 1999, is an Estonian genetic testing company with a series of well established DNA tests. Products and services: 1) DNA testing - Asper Biotech gene tests - Asper Ophthalmics gene tests (ophthalmogenetic disorders) 2) Customized chip development (SNPs and mutations) 3) Genorama platform (SNPs and mutations detection) | | Main activity/research area
Medicine, Human Health, Diagnostics, Diagnosis, Medical Technology / Biomedical Engineering, Laboratory Equipment, Micro- and Nanotechnology related to Biological sciences | | | | Main cooperation areas
Domains we are interested in: DNA diagnostics Our interests: – to develop customized SNP and mutation chips in various genetic disorders (microarray technology, in the range of 100-1000 SNP/mutation) – to mediate Swedish gene diagnostic tests in Estonia
|
|
| indrek.kask@bioatlas.com | | Bioatlas | | Tartu | | Estonia | | www.bioatlas.com | | Company profile
Bioatlas is an advancing European biotechnology company providing high quality molecular biology products to researchers, distributors and OEM resellers. We started Bioatlas with the intention of establishing a portfolio of molecular biology reagents, so that people would be able to find many products they need from a single source, giving our customers the opportunity to spend less time thinking about the reagents they use and more time on their research.
There are a number of organizations, which have developed and are producing innovative and high-quality life-sciences products. The fact is, often these companies lack the experience and capital to succeed in the commercialization of their products. Bioatlas provides these companies with the sales and marketing functions, which otherwise would take significant investments and time to set up. We also provide these companies with market pull R&D ideas, which we can bring to the market together. | | Main activity/research area
Biology / Biotechnology | | laboratory supplies | | Main cooperation areas
We are looking for partners with the following characteristics:
- R&D organizations with innovative products which are close to marketable or ready for the market
- Production organizations with innovative products which need another sales channel
- Sales organizations, which have established a strong network of clients
|
|
| tarmo@celecure.com | | Celecure Ltd | | Tallinn | | Estonia | | www.celecure.com | | Company profile
Celecure, Ltd., a privately-held biotechnology company, is a drug discovery and development company focusing on cancer. We are developing a pipeline of novel treatments and diagnostics targeting unmet needs in a broad spectrum of prevalent conditions. With three leading projects in pipeline and assembled team of skilled and motivated scientists Celecure plans to file it´s first IND in 2009. | | Main activity/research area
Pharmaceutical Products / Drugs, Biochemistry/biophysics | | | | Main cooperation areas
- Celecure is looking for a strong partner for its protein based angioinhibitor SB101. The partner should be preferably with an expertise on development of biological drugs. Possible partnership could be complete licensing, collaborative research, and development of new indications.
- Celecure could develop an Entrybody of interest both for scientific and clinical purposes.
|
|
| atasa@ebc.ee | | TBD-Biodiscovery | | Tartu | | Estonia | | www.biodiscovery.eu | | Company profile
TBD-Biodiscovery is an innovative contract research company in Estonia focusing its activities towards synthetic and analytical chemistry | | Main activity/research area
Medicine, Human Health, Medical Research, Pharmaceutical Products / Drugs, Medical Biomaterials, Biochemistry/biophysics | | | | Main cooperation areas
Synthetic chemistry services
|
|
| jaanus.pikani@steri.ee | | AS Steri | | Tallinn | | Estonia | | www.steri.ee | | Company profile
Production of medical consumables
Irradiation sterilization
| | Main activity/research area
Medical Technology / Biomedical Engineering | | | | Main cooperation areas
Production of medical consumables
Irradiation sterilization
|
|
| | | Contact: Małgorzata | Podhajska |
| symbios@symbios.com.pl | | Symbios | | Straszyn | | Poland | | www.symbios.com.pl | | Company profile
Symbios Ltd. is a distributing company held in 1995 in Gdańsk.
We supply end user with the highly advanced life science products developed thorough world leading biotech companies.
We represent on Polish market such companies as: Promega, Perbio, Owl, MBP, UVP, UniEqiup. | | Main activity/research area
Diagnostics, Diagnosis, Pharmaceutical Products / Drugs, Laboratory Equipment, Biology / Biotechnology , Biochemistry/biophysics | | distributing company | | Main cooperation areas
life science products
|
|
| graage@steinbeis-nordost.de | | Steinbeis-Forschungszentrum Technologie-Management Nordost | | Rostock | | Germany | | www.steinbeis-nordost.de | | Company profile
- Management of research consortia
- Exploitation of results/technology transfer
- Representing science organisations from Rostock Germany - region in ophthalmology, bioinformatics, biophysics | | Main activity/research area
Medical Technology / Biomedical Engineering, Micro- and Nanotechnology related to Biological sciences , Biochemistry/biophysics, Bioinformatics | | | | Main cooperation areas
|
|
| ttalpsep@quattromed.ee | | Quattromed Ltd. | | Tartu | | Estonia | | www.quattromed.com | | Company profile
Quattromed is an innovative biotech company that has focused its activities towards medical diagnostics and pharmaceutical research. With our team of 80 highly skilled professionals, we provide:
* medical diagnostic services;
* technology development programs (QMCF®);
* technology for production of recombinant proteins;
* custom research programs for the biopharmaceutical industry;
* natural rubber latex allergen testing of rubber materials (FITkit®);
* life science products (monoclonal antibodies, epitope tagging kits, enzymes, DNA purification kits).
We are devoted to understand the needs of our customers. This helps us to design services and partnerships in the best possible way. The main focus of our activities is on protein expression and production. In-house proprietary technologies are combined with extensive process know-how and partnership with academic and industrial groups.
The management system of Quattromed Group (including Quattromed Cell Factory) complies with the requirements of the ISO 9001:2000 standard. | | Main activity/research area
* Distribution/dealers of our products
* Participation in technology development consortiums as technology/services provider
* Customers who need recombinant proteins, recombinant cell lines and/or technology license for protein production and cell line development
* Technology partners to bring our services to new level | | | | Main cooperation areas
- Distribution/dealers of our products - Participation in technology development consortiums as technology/services provider - Technology partners to bring our services to new level
|
|
| info@neuroproof.com | | NeuroProof GmbH | | Rostock | | Germany | | www.neuroproof.com | | Company profile
Neuroproof offers drug-screening services for preclinical research with its Neuroproof-technology which comprises of in-vitro neuronal cell cultures, microelectrode-arrays and pattern recognition methods. | | Main activity/research area
Medical Research, Pharmaceutical Products / Drugs, Biochemistry/biophysics, Bioinformatics | | | | Main cooperation areas
- CNS-drug development
- toxicology
- microelectrode-arrays
|
|
| | | Contact: Camilla | Wernersson |
| camilla.wernersson@idg.se | | Biotech Sweden | | Stockholm | | Sweden | | | | Company profile
News service for life science | | Main activity/research area
| | Media | | Main cooperation areas
|
|
| bertil@life-science.se | | European Life Science Journal | | Stockholm | | Sweden | | www.europeanlifescience.eu | | Company profile
A life science journal, building bridges between companies/organisations and clusters in Europe and rest of the world | | Main activity/research area
Biostatistics, Diagnostics, Diagnosis, Medical Research, Pharmaceutical Products / Drugs, Laboratory Equipment, Biology / Biotechnology , Micro- and Nanotechnology related to Biological sciences , Bioinformatics | | | | Main cooperation areas
|
|
| peter.classen@novasep.com | | Groupe Novasep | | Leverkusen | | Germany | | www.novasep.com | | Company profile
Novasep is a French group employing 1300 people specializing in chemical synthesis and purification for the pharmaceutical industry. We offer our services in contract manufacture at industrial scale (from a few grams up to tonnes) under cGMP but are equally at home in separation technology (as a customer services or as apparature supplier).
Some references we can disclose are as follows:
- We have just signed a 5 year partnership agreement with Solvay for the synthesis of 2 API’s at Finorga in France
- We are involved in producing an intermediate for Roche’s Tamiflu thanks to our ability to handle hazardous chemicals at Dynamit Nobel in Leverkusen, Germany (sodium azide, diborane, diazomethane and others…)
- We are a worldwide leader in semi-synthetic Paclitaxel and other cytotoxic compounds at our dedicated Highly Potent Active Ingredients facility Seripharm in Le Mans
- We have different generic API´s and building blocks we sell or work on - Nitroglycerine, Mitsunobu-reactants, Chiral Separation of future API´s, etc.
- More than 70% of insulin is purified on Novasep´s purification equipment
Novasep offers a unique combination of multi –step synthesis and batch or continuous (SMB) preparative chromatography.
| | Main activity/research area
Pharmaceutical Products / Drugs, Biology / Biotechnology | | Exclusive Synthesis | | Main cooperation areas
|
|
| hanna.jakobsson@tataa.com | | TATAA Biocenter | | Göteborg | | Sweden | | www.tataa.com | | Company profile
TATAA Biocenter AB, with centers in Göteborg, San Francisco, Prague and Munich, offers research services for the academia and industry. We provide commissioned research and education within molecular diagnostics, gene expression analysis and offer innovative products for researchers. Our fields of expertise are gene expression profiling, pathogen detection and analysis of small samples down to single cells. TATAA Biocenter is a profitable and expanding international company.
| | Main activity/research area
Biostatistics, Medical Research | | | | Main cooperation areas
Pharma industry, biotechnology companies, biomaterial compaies
|
|
| tl@biomotif.com | | Biomotif AB | | Danderyd | | Sweden | | www.biomotif.com | | Company profile
Research and development of Electrocapture technology for/and Mass Spectrometry.
| | Main activity/research area
Medicine, Human Health, Pharmaceutical Products / Drugs, Laboratory Equipment, Biology / Biotechnology , Biochemistry/biophysics | | | | Main cooperation areas
I seek collaboration partners for example around novel quantatative software solutions.
|
|
| henrik.sjostrom@tataa.com | | TATAA Biocenter | | Göteborg | | Sweden | | www.tataa.com | | Company profile
TATAA Biocenter AB, with centers in Göteborg, San Francisco, Prague and Munich, offers research services for the academia and industry. We provide commissioned research and education within molecular diagnostics, gene expression analysis and offer innovative products for researchers. Our fields of expertise are gene expression profiling, pathogen detection and analysis of small samples down to single cells. TATAA Biocenter is a profitable and expanding international company.
| | Main activity/research area
Biostatistics, Medical Research | | | | Main cooperation areas
Pharma industry, biomaterial companies, biotech
|
|
| lunde@cbs.dtu.dk | | Danmarks Tekniske Universitet - DTU | | Kgs. Lyngby | | Denmark | | www.cbs.dtu.dk | | Company profile
DTU covers many areas within the technical sciences.
DTU has successful research working relationships with a large number of small and medium-sized businesses, GTS Institutes and other research institutions in Denmark and abroad. Through collaboration, DTU aims to provide a targeted contribution to high-tech and knowledge-based development of all businesses and interested parties within the same field. As a result, DTU enters into agreements on research working relationships with more than 200 different Danish and foreign businesses every year. The research working relationship can be financed through joint applications to research councils, through innovation funds or contributions by the business.
The Immunological bioinformatics group, Center for Biological Sequence Analysis - CBS, at the department of Systems Biology is especially focused on epitope discovery. We have developed sophisticated in silico methods for fast identification of potential epitopes in full genomes, and integrate genome comparison for identification of conserved/variable epitopes. The tools have been validated on several bacterial and viral pathogens. The expertise within this group is especially useful in rational vaccine design, epitope based diagnostics and development of immuno-therapeutics | | Main activity/research area
Medicine, Human Health, Diagnostics, Diagnosis, Medical Technology / Biomedical Engineering, Pharmaceutical Products / Drugs, Biology / Biotechnology , Bioinformatics | | vaccinology | | Main cooperation areas
We would like to find industrial cooperation for specific product development of immunotherapeutics, vaccines or diagnostics using the tools and expertise within this group.
|
|
| mniel@cbs.dtu.dk | | Danmarks Tekniske Universitet - DTU | | Lyngby | | Denmark | | www.cbs.dtu.dk | | Company profile
DTU covers many areas within the technical sciences. DTU has successful research working relationships with a large number of small and medium-sized businesses, GTS Institutes and other research institutions in Denmark and abroad. Through collaboration, DTU aims to provide a targeted contribution to high-tech and knowledge-based development of all businesses and interested parties within the same field. As a result, DTU enters into agreements on research working relationships with more than 200 different Danish and foreign businesses every year. The research working relationship can be financed through joint applications to research councils, through innovation funds or contributions by the business. The Immunological bioinformatics group, Center for Biological Sequence Analysis - CBS, at the department of Systems Biology is especially focused on epitope discovery. We have developed sophisticated in silico methods for fast identification of potential epitopes in full genomes, and integrate genome comparison for identification of conserved/variable epitopes. The tools have been validated on several bacterial and viral pathogens. The expertise within this group is especially useful in rational vaccine design, epitope based diagnostics and development of immuno-therapeutics | | Main activity/research area
Medicine, Human Health, Diagnostics, Diagnosis, Medical Technology / Biomedical Engineering, Pharmaceutical Products / Drugs, Biology / Biotechnology , Bioinformatics | | vaccinology | | Main cooperation areas
We would like to find industrial cooperation for specific product development of immunotherapeutics, vaccines or diagnostics using the tools and expertise within this group.
|
|
| frank.lindh@isosep.com | | IsoSep AB | | Tullinge | | Sweden | | www.isosep.com | | Company profile
IsoSep AB
has - since 1991 - provided the research community with fine chemicals. We can, in addition to this, offer our customers in industry and academia, organic synthesis with an edge in carbohydrate and medicinal chemistry.
Our services range from synthesis of single compounds for R&D purposes (up to kg scale) to explorative synthesis of compounds. Our staff has extensive experience in synthetic organic chemistry drawn from previous engagements in industry and academia, encompassing both traditional organic synthesis, solid-phase and enzymatic synthesis, as well as separation of complex product mixtures.
IsoSep's main laboratory is located in Uppsala, Sweden. The laboratory is fully equipped for separations and synthesis in up to kg scale, and has, in the same building, access to 400 and 600 MHz NMR spectrometers and mass spectrometers. | | Main activity/research area
Pharmaceutical Products / Drugs, Biology / Biotechnology , Biochemistry/biophysics | | Carbohydrate Fine Chemicals
Neoglycoproteins (Oligosaccharide-Protein Conjugates)
Immobilized Oligosaccharides
Glycosphingolipids
Gangliosides
Standards | | Main cooperation areas
Contract synthesis
CRO-field
|
|
| kukku513@yahoo.se | | IsoSep AB | | Uppsala | | Sweden | | | | Company profile
fine chemicals, custom synthesis | | Main activity/research area
Pharmaceutical Products / Drugs | | | | Main cooperation areas
|
|
| mallen.huang@3hbiomedical.com | | 3H Biomedical AB | | Uppsala | | Sweden | | www.3hbiomedical.com | | Company profile
3H Biomedical develops and markets high-value primary cells and cell-based products for life science and drug discovery. Today the company is supplying: (1) Primary cells (Human, Mouse, Rat, Dog), medium ; (2) Cell and Tissue Chips; (3) RNA; (4) Proteins; (5) Genomic DNA and (6) Human blood serum and plasma.
Our mission is to provide superior products on a global basis.
The company’s R&D focus is on developing cell-based assays and therapeutic vaccines. We are actively seeking partners in order to develop our innovative cell immune therapy technology platform for the treatment of human diseases.
3H Biomedical is located in Uppsala Science Park, Sweden, just 35 km from Arlanda international airport.
| | Main activity/research area
Medicine, Human Health, Medical Research, Medical Technology / Biomedical Engineering, Medical Biomaterials, Biology / Biotechnology | | Contract R&D services | | Main cooperation areas
Developing and marketing bioscience products
Contract R&D services
|
|
| | | Contact: Krzysztof | Bielawski |
| bielawski@biotech.ug.gda.pl | | University fo Gdańsk | | Gdansk | | Poland | | | | Company profile
Intercollegiate Faculty of Biotechnology UG-MUG, research and education, | | Main activity/research area
Medicine, Human Health, Diagnostics, Diagnosis, Medical Research, Biology / Biotechnology | | | | Main cooperation areas
Oncology research and diagnostics, molecular diagnostics of infectious diseases
|
|
| rolkrieg@gmx.de | | Indivicon Diagnostics ltd. | | Ochtrup | | Germany | | indivicon.org | | Company profile
The aim of INDIVICON Diagnositcs ltd. is to bring the concept of individualized cancer treatment to the resident physicians who care for the cancer patients and to the patients themselves via their own support groups. A special focus is laid on the support of targeted and immune therapy as individualized tracks in cancer therapy. Furthermore, archival tumor FFPE material is re-evaluate a therapy which could have taken place years before and to derive criteria for an actual further targeted or complementary therapy of the patient. | | Main activity/research area
Medicine, Human Health, Diagnostics, Diagnosis, Medical Technology / Biomedical Engineering, Pharmaceutical Products / Drugs, Medical Biomaterials | | | | Main cooperation areas
|
|
| bu.brandt@uke.uni-hamburg.de | | University Medical Centre Hamburg-Eppendorf | | Hamburg | | Germany | | www.uke.uni-hamburg.de | | Company profile
The research group of Prof. Brandt focuses on the detection and characterization of genetic aberrations as specific events and their consequences for signal transduction in the progression of breast, prostate and ovarian cancer. Special emphasis is given to the HER-family tyrosine kinase receptors and related pathways. Furthermore, methods have been developed for the earliest detection of invasive and metastatic cancer cells and the application of genetic analysis on a few or single cells. The group comprises chemists, biologists, physicians and biomathematics who are experienced in a broad spectrum of methods in molecular biology to perform highly sophisticated research projects. The research resulted in highly ranked publications and patent applications. | | Main activity/research area
Medicine, Human Health, Diagnostics, Diagnosis, Medical Research, Micro- and Nanotechnology related to Biological sciences | | | | Main cooperation areas
Oncology, minimal. residual disease, thechnology for sensitive geentic analysis of tumor cels, circulating tumor cells
|
|
| antti.pirnes@patiq.com | | Patiq | | Espoo | | Finland | | www.patiq.com | | Company profile
Patiq is a Finland based technology intelligence company.
To provide answers to your technology and business challenges, we will deliver you professional, prompt and precise patent analysis created by using powerful commercial databases. Furthermore the most demanding novelty, freedom to operate, patent landscaping, competitor and partner monitoring and other patent related analyst requests covering all source languages are within our scope of expertise. | | Main activity/research area
Biology / Biotechnology | | | | Main cooperation areas
- Services for bioscience companies
- Technology partners to bring our services to the next level
|
|
| info@bestenbalt.com | | Bestenbalt OÜ | | Tallinn | | Estonia | | www.bestenbalt.com | | Company profile
Bestenbalt LLC is a privately held biotechnology company that specializes on production of recombinant and natural proteins, peptides, and their derivatives. In parallel biomedical research for therapeutic use of various proteins is carried out.
| | Main activity/research area
Medical Research, Biology / Biotechnology , Biochemistry/biophysics | | | | Main cooperation areas
|
|
| kurt.skold@hammercap.se | | Hammercap Medical AB | | Stockholm | | Sweden | | www.hammercap.se | | Company profile
Development of clinical methods, technology and boron drugs for Boron Neutron Capture Therapy (BNCT) | | Main activity/research area
Medicine, Human Health, Medical Research, Medical Technology / Biomedical Engineering, Pharmaceutical Products / Drugs | | | | Main cooperation areas
Drug development and hardware for Boron Neutron Capture Therapy (BNCT)
|
|
| |
|
